Di Ge

3.4k total citations
114 papers, 2.5k citations indexed

About

Di Ge is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Di Ge has authored 114 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Molecular Biology, 36 papers in Pulmonary and Respiratory Medicine and 25 papers in Oncology. Recurrent topics in Di Ge's work include Lung Cancer Diagnosis and Treatment (15 papers), RNA modifications and cancer (13 papers) and Esophageal Cancer Research and Treatment (13 papers). Di Ge is often cited by papers focused on Lung Cancer Diagnosis and Treatment (15 papers), RNA modifications and cancer (13 papers) and Esophageal Cancer Research and Treatment (13 papers). Di Ge collaborates with scholars based in China, United Kingdom and United States. Di Ge's co-authors include Jie Gu, Yin Li, Chunlai Lu, Chunlai Lu, Fengkai Xu, Jun‐Ying Miao, Yiwei Chu, Bao‐Xiang Zhao, Zongwu Lin and Le Su and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Di Ge

107 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Ge China 28 1.4k 634 606 539 279 114 2.5k
So Dug Lim South Korea 28 1.4k 1.0× 528 0.8× 784 1.3× 533 1.0× 419 1.5× 92 2.8k
Akio Horiguchi Japan 28 940 0.7× 617 1.0× 684 1.1× 586 1.1× 546 2.0× 161 2.4k
Wei He China 27 1.3k 1.0× 797 1.3× 526 0.9× 558 1.0× 338 1.2× 134 2.9k
Anca Maria Cîmpean Romania 24 1.2k 0.9× 563 0.9× 395 0.7× 1.0k 1.9× 355 1.3× 180 2.9k
Gang Deng China 26 667 0.5× 453 0.7× 426 0.7× 354 0.7× 351 1.3× 90 1.9k
Olivier Dormond Switzerland 33 1.7k 1.3× 584 0.9× 323 0.5× 1.1k 2.1× 260 0.9× 72 3.3k
B. Smith United States 24 897 0.7× 304 0.5× 698 1.2× 587 1.1× 345 1.2× 84 2.2k
Meiju Ji China 35 2.1k 1.5× 685 1.1× 388 0.6× 784 1.5× 276 1.0× 116 3.5k
Li Ren Kong China 23 887 0.7× 476 0.8× 501 0.8× 646 1.2× 176 0.6× 77 2.0k

Countries citing papers authored by Di Ge

Since Specialization
Citations

This map shows the geographic impact of Di Ge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Ge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Ge more than expected).

Fields of papers citing papers by Di Ge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Ge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Ge. The network helps show where Di Ge may publish in the future.

Co-authorship network of co-authors of Di Ge

This figure shows the co-authorship network connecting the top 25 collaborators of Di Ge. A scholar is included among the top collaborators of Di Ge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Ge. Di Ge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Mengjia, Tingting Luo, Wenying Yin, et al.. (2025). Ent-pimarane and ent-kaurane diterpenoids from Siegesbeckia pubescens and their anti-endothelial damage effect in diabetic retinopathy. Chinese Journal of Natural Medicines. 23(2). 234–244.
2.
Zhang, Yuchen, Yifan Guo, Hongyu Zhang, et al.. (2025). tRF3a-MetCAT Promotes EGFR-Targeted Therapeutic Resistance through the TRIM21–STAT1–C5a Axis in Lung Adenocarcinoma. Research. 8. 911–911.
3.
Ge, Di, Tingting Luo, Mengjia Liu, et al.. (2024). Natural diterpenoid EKO activates deubiqutinase ATXN3 to preserve vascular endothelial integrity and alleviate diabetic retinopathy through c-fos/focal adhesion axis. International Journal of Biological Macromolecules. 260(Pt 2). 129341–129341. 6 indexed citations
5.
Li, Yin, Li Luo, Yong Zhang, et al.. (2024). UPP1 promotes lung adenocarcinoma progression through the induction of an immunosuppressive microenvironment. Nature Communications. 15(1). 1200–1200. 28 indexed citations
6.
Zhang, Yuchen, et al.. (2024). Major pathological response obtained after neoadjuvant chemotherapy combined with dual immunotherapy for malignant pleural mesothelioma: a case report. Translational Lung Cancer Research. 13(6). 1420–1425. 1 indexed citations
7.
Liu, Na, et al.. (2023). Natural compound So-2 suppresses triple-negative breast cancer through inducing ferroptosis via downregulating transcription factor E2F7. Archives of Biochemistry and Biophysics. 744. 109694–109694. 8 indexed citations
8.
Lin, Tong, Jiayuan Sun, Xiaoju Zhang, et al.. (2022). Diagnostic value of tumor associated autoantibody panel in early detection of lung cancer in Chinese population: Protocol for a prospective, observational, and multicenter clinical trial. SHILAP Revista de lepidopterología. 5. 67–71. 1 indexed citations
9.
Ma, Teng, et al.. (2022). BIRC5 Modulates PD-L1 Expression and Immune Infiltration in Lung Adenocarcinoma. Journal of Cancer. 13(10). 3140–3150. 15 indexed citations
10.
Yang, Dawei, Chuanjia Gu, Xiaodong Zhang, et al.. (2022). Electrical Impedance Analysis for Lung Cancer: A Prospective, Multicenter, Blind Validation Study. Frontiers in Oncology. 12. 900110–900110. 5 indexed citations
11.
Zhang, Long, et al.. (2021). Study on Pressure Relief Effect and Rock Failure Characteristics with Different Borehole Diameters. Shock and Vibration. 2021(1). 10 indexed citations
12.
Wang, Shuya, F. M. Meng, Min Li, et al.. (2020). Cilostazol alleviate nicotine induced cardiomyocytes hypertrophy through modulation of autophagy by CTSB/ROS/p38MAPK/JNK feedback loop. International Journal of Biological Sciences. 16(11). 2001–2013. 24 indexed citations
13.
Zhu, Qiaoliang, Rongkui Luo, Jie Gu, et al.. (2019). High CXCR4 Expression Predicts a Poor Prognosis in Resected Lung Adenosquamous Carcinoma. Journal of Cancer. 11(4). 810–818. 9 indexed citations
14.
Liu, Shuyan, Xiangqian Kong, Di Ge, et al.. (2016). Identification of New Small Molecules as Apoptosis Inhibitors in Vascular Endothelial Cells. Journal of Cardiovascular Pharmacology. 67(4). 312–318. 5 indexed citations
15.
Guo, Jing, Jie Gu, Zongwu Lin, et al.. (2015). Regulation of CXCR4/AKT-signaling-induced cell invasion and tumor metastasis by RhoA, Rac-1, and Cdc42 in human esophageal cancer. Tumor Biology. 37(5). 6371–6378. 27 indexed citations
16.
Liu, Ronghua, Jie Gu, Pei Jiang, et al.. (2014). DNMT1–MicroRNA126 Epigenetic Circuit Contributes to Esophageal Squamous Cell Carcinoma Growth via ADAM9–EGFR–AKT Signaling. Clinical Cancer Research. 21(4). 854–863. 95 indexed citations
17.
Zhang, Jingchuan, Jing Lv, Zheng Li, et al.. (2012). Trastuzumab anti-tumor efficacy in patient-derived esophageal squamous cell carcinoma xenograft (PDECX) mouse models. Journal of Translational Medicine. 10(1). 180–180. 36 indexed citations
18.
Ge, Di, et al.. (2010). Surgical management of aortoesophageal fistula caused by foreign bodies. European Journal of Cardio-Thoracic Surgery. 40(1). 13–16. 10 indexed citations
19.
Ge, Di, et al.. (2009). Expression of HER4 in esophageal carcinoma tissues and its clinical significance.. Tumori. 29(7). 673–676. 2 indexed citations
20.
Lu, Chunlai, Weigang Guo, Jianyong Ding, & Di Ge. (2008). Clinical and pathological analysis of solitary fibrous tumor of the pleura. 24(2). 91–94. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026